Drug comparisons
Saxagliptin vs Acetohexamide
Compare Saxagliptin and Acetohexamide for type 2 diabetes. DPP-4 inhibitor Saxagliptin offers lower hypoglycemia risk than the older sulfonylurea Acetohexamide.
No comparison dimensions are available for this page.
Clinical context
This comparison typically arises when evaluating a switch from an older first-generation sulfonylurea to a modern DPP-4 inhibitor for safer type 2 diabetes control.
Bottom line
Saxagliptin is generally preferred over Acetohexamide in current practice due to its better safety profile and lower hypoglycemia risk.
All medication comparisons